Prion Protein Prevents Human Breast Carcinoma Cell Line from Tumor Necrosis Factor α-Induced Cell Death

To define genetic determinants of tumor cell resistance to the cytotoxic action of tumor necrosis factor α (TNF), we have applied cDNA microarrays to a human breast carcinoma TNF-sensitive MCF7 cell line and its established TNF-resistant clone. Of a total of 5760 samples of cDNA examined, 3.6% were found to be differentially expressed in TNF-resistant 1001 cells as compared with TNF-sensitive MCF7 cells. On the basis of available literature data, the striking finding is the association of some differentially expressed genes involved in the phosphatidylinositol-3-kinase/Akt signaling pathway. More notably, we found that the PRNP gene coding for the cellular prion protein (PrPc), was 17-fold overexpressed in the 1001 cell line as compared with the MCF7 cell line. This differential expression was confirmed at the cell surface by immunostaining that indicated that PrPc is overexpressed at both mRNA and protein levels in the TNF-resistant derivative. Using recombinant adenoviruses expressing the human PrPc, our data demonstrate that PrPc overexpression converted TNF-sensitive MCF7 cells into TNF-resistant cells, at least in part, by a mechanism involving alteration of cytochrome c release from mitochondria and nuclear condensation.

[1]  S. Chouaib,et al.  Alteration of the Sphingomyelin/Ceramide Pathway Is Associated with Resistance of Human Breast Carcinoma MCF7 Cells to Tumor Necrosis Factor-α-mediated Cytotoxicity* , 1997, The Journal of Biological Chemistry.

[2]  S. Chouaib,et al.  Resistance to TNF-Induced Cytotoxicity Correlates with an Abnormal Cleavage of Cytosolic Phospholipase A21 , 2000, The Journal of Immunology.

[3]  H. Haddada,et al.  Adenovirus‐mediated wild‐type‐p53‐gene expression sensitizes TNF‐resistant tumor cells to TNF‐induced cytotoxicity by altering the cellular redox state , 2000, International journal of cancer.

[4]  C. Badie,et al.  Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb , 1999, Oncogene.

[5]  M. Jäättelä,et al.  A20 zinc finger protein inhibits TNF and IL-1 signaling. , 1996, Journal of immunology.

[6]  C. Moyret-Lalle,et al.  Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function , 1997, Oncogene.

[7]  Tao Yan,et al.  Overexpression of Manganese Superoxide Dismutase Suppresses Tumor Necrosis Factor-induced Apoptosis and Activation of Nuclear Transcription Factor-κB and Activated Protein-1* , 1998, The Journal of Biological Chemistry.

[8]  S. Duprat,et al.  [IMAGE: molecular integration of the analysis of the human genome and its expression]. , 1995, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[9]  D. Dormont,et al.  Nervous and nonnervous cell transduction by recombinant adenoviruses that inducibly express the human PrP. , 2001, Biochemical and biophysical research communications.

[10]  R. Brentani,et al.  Laminin‐induced PC‐12 cell differentiation is inhibited following laser inactivation of cellular prion protein , 2000, FEBS letters.

[11]  C Eng,et al.  PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. , 2001, Human molecular genetics.

[12]  W. Fiers.  Tumor necrosis factor Characterization at the molecular, cellular and in vivo level , 1991, FEBS letters.

[13]  T. Cotter,et al.  Prion Protein Fragment PrP-(106–126) Induces Apoptosis via Mitochondrial Disruption in Human Neuronal SH-SY5Y Cells* , 2001, The Journal of Biological Chemistry.

[14]  M. Schachner,et al.  Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival , 2003, Molecular and Cellular Neuroscience.

[15]  C. Kurschner,et al.  Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. , 1996, Brain research. Molecular brain research.

[16]  P. Klöhn,et al.  Transmission of prions , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Linden,et al.  Cellular prion protein transduces neuroprotective signals , 2002, The EMBO journal.

[18]  S. Prusiner,et al.  Prion biology and diseases. , 1999, Harvey lectures.

[19]  A. Gautreau,et al.  Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Sisodia.  Nuclear Inclusions in Glutamine Repeat Disorders Are They Pernicious, Coincidental, or Beneficial? , 1998, Cell.

[22]  A. Aguzzi,et al.  7 Knockouts, Transgenics, and Transplants in Prion Research , 1999 .

[23]  D. Dormont,et al.  The 37‐kDa/67‐kDa laminin receptor acts as the cell‐surface receptor for the cellular prion protein , 2001, The EMBO journal.

[24]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[25]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[26]  A. LeBlanc,et al.  Prion Protein Protects Human Neurons against Bax-mediated Apoptosis* , 2001, The Journal of Biological Chemistry.

[27]  M. Jäättelä,et al.  Hsp70 exerts its anti‐apoptotic function downstream of caspase‐3‐like proteases , 1998, The EMBO journal.

[28]  José Luis de la Pompa,et al.  Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.

[29]  F. Checler,et al.  Overexpression of PrPc triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti‐PrP antibodies , 2002, Journal of neurochemistry.

[30]  Robin Fahraeus,et al.  Cellular Prion Protein Sensitizes Neurons to Apoptotic Stimuli through Mdm2-regulated and p53-dependent Caspase 3-like Activation* , 2003, The Journal of Biological Chemistry.

[31]  S. Itohara,et al.  Prions prevent neuronal cell-line death , 1999, Nature.

[32]  D. Dormont,et al.  Identification of interaction domains of the prion protein with its 37‐kDa/67‐kDa laminin receptor , 2001, The EMBO journal.

[33]  A. Burlingame,et al.  Stress‐inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection , 2002, The EMBO journal.

[34]  M. Soares,et al.  Construction and characterization of a normalized cDNA library. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Kroemer,et al.  Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria , 2002, Cancer Gene Therapy.

[36]  R. Clarke,et al.  Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. , 1994, Cancer research.